x
- Home
- About Diabetes
- Services
- Diabetes Mellitus Modeling Solutions
- R&D Services for Diabetes Mellitus and Diabetic Complications
- By Drug Development Process
- About Us
- Careers
- Contact Us
Cat. No.: DAA-001036
| Product Information | |
|---|---|
| Product Name | Human Fetuin-A ELISA Kit |
| Species | Human |
| Description | Human Fetuin-A ELISA Kit is a single-wash 90 min sandwich ELISA designed for the quantitative measurement of Fetuin-A protein in cell culture supernatant, edta plasma, serum, and cit plasma. It uses our proprietary ELISA technology. Quantitate Human Fetuin-A with 116.24 pg/mL sensitivity ELISA technology employs capture antibodies conjugated to an affinity tag that is recognized by the monoclonal antibody used to coat our ELISA plates. This approach to sandwich ELISA allows the formation of the antibody-analyte sandwich complex in a single step, significantly reducing assay time. |
| Sample Types | Cell Culture Supernatant, Serum, Edta Plasma, Cit Plasma |
| Detection Range | 203.13 pg/mL - 13000 pg/mL |
| Sensitivity | 116.24 pg/mL |
| Target Information | |
|---|---|
| Target Name | AHSG |
| UniProt No. | P02765 |
| Gene ID | 197 |
| Target Description | Promotes endocytosis, possesses opsonic properties and influences the mineral phase of bone. Shows affinity for calcium and barium ions. |
| Alternative Names | 59 kDa bone sialic acid-containing protein; A2HS; Aa2-066; AHS; Ahsg; Ahsg alpha-2-HS-glycoprotein; Alpha 2 HS Glycoprotein; Alpha 2 Z globulin; Alpha-2-HS-glycoprotein; Alpha-2-HS-glycoprotein chain B; Alpha-2-Z-globulin; Asialofetuin; Ba alpha 2 glycoprotein; Ba-alpha-2-glycoprotein; BSP; Countertrypin; Fetua; FETUA_HUMAN; Fetuin, mouse, homolog of; Fetuin A; Fetuin-A; Glycoprotein PP63; HSGA; pp63 |
| Shipping & Storage | |
|---|---|
| Sipping | Shipping on dry ice. |
| Storage | Store at +4°C. Please refer to protocols. |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.
